4/10/2014 7:17:48 AM
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that collaborators from the University of California, San Francisco (UCSF) presented results at the 2014 American Association for Cancer Research (AACR) conference, April 5-9, 2014 in San Diego, CA, highlighting the potential utility of imaging agents derived from Navidea’s Manocept™ platform in identifying affected tissues and lymph nodes in patients with Kaposi Sarcoma (KS).
Help employers find you! Check out all the jobs and post your resume.
comments powered by